Synthetic Biologics acquires VCN Biosciences
14 Mar 2022 //
PHARMABIZ
Synthetic Biologics Completes Acquisition of VCN Biosciences
11 Mar 2022 //
GLOBENEWSWIRE
US FDA grants ODD to VCN Biosciences` VCN-01 for retinoblastoma
10 Feb 2022 //
PHARMABIZ